ArticleFrontiers in immunology2024

Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors.

Na Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.